Propofol-ketamine combination therapy for effective control of super-refractory status epilepticus

Epilepsy and Behavior

Volumn 52, Issue , 2015, Pages 264-266

  Sabharwal, Vivek ^a   Ramsay, Eugene ^a   Martinez, Raisa ^b   Shumate, Rachel ^a   Khan, Fawad ^a   Dave, Hina ^a   Iwuchukwu, Ifeanyi ^a   McGrade, Harold ^a  

^a OCHSNER MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Anesthetic agents; Ketamine; Mortality; Propofol; Seizure control; Super refractory status epilepticus; Treatment

Indexed keywords

DOPAMINE; KETAMINE; NORADRENALIN; PROPOFOL; VASOPRESSIN; ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; VASOCONSTRICTOR AGENT;

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CHILD; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG EFFICACY; DRUG RESPONSE; EPILEPTIC STATE; FEMALE; FLUID RESUSCITATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORTALITY; RETROSPECTIVE STUDY; SUPER REFRACTORY STATUS EPILEPTICUS; TREATMENT DURATION; COMBINATION DRUG THERAPY; DRUG RESISTANT EPILEPSY; HYPOXIA, BRAIN; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; STATUS EPILEPTICUS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANESTHETICS, DISSOCIATIVE; ANESTHETICS, INTRAVENOUS; CHILD; CRITICAL CARE; DRUG RESISTANT EPILEPSY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOXIA, BRAIN; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; PROPOFOL; RETROSPECTIVE STUDIES; STATUS EPILEPTICUS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84945551160     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.07.040     Document Type: Article

References (6)

1. Shorvon S., Ferlisi M. The treatment of super refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011, 134:2802-2818.
2. Zeiler F.A. Early use of the NMDA receptor antagonist ketamine in the refractory and super refractory status epilepticus. Crit Care Res Pract 2015, 1-5. (01/2015).
3. Gaspard N., et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 2013, 54:1498-1503.
4. Synowiec A.S., et al. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res 2013, 105(1-2):183-188.
5. Power K., Flaatten H., et al. Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. Epilepsy Res 2011, 94:53-60.
6. Roberts R.J., Barletta J.F., et al. Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care Med 2009, 13:R169.